Cytokine Polymorphisms, Their Influence and Levels in Brazilian Patients with Pulmonary Tuberculosis during Antituberculosis Treatment
Figure 5
Influence of IL17 SNP rs7747909 on IL-17 plasma levels (a) and mRNA expression (b) in the control group (C) and PTB patients group at three time points of the treatment: T1 (after diagnosis and first month), T2 (three months), and T3 (six months). Data are shown as median levels. *.
